These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8872968

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA.
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L, Chasseuil E, Rabot N, Paintaud G, François M, Birmelé B, Darrouzain F, Büchler M, Halimi JM, Ternant D.
    Nephron; 2017 Jul; 135(4):261-267. PubMed ID: 28152540
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F, Uehlinger DE.
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a vancomycin dosing regimen for patients on high flux hemodialysis: an observational study.
    Soto Guerrero Y, Hernández Castillo R, Santiago E, Ramírez Yuch N, Jaume Anselmi F, Jové R, Flores R, Lebrón R, Ramírez Rivera J.
    Bol Asoc Med P R; 2012 Jan; 104(3):10-4. PubMed ID: 23156886
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA, Ariano RE, McCrae ML, Vercaigne LM.
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [Abstract] [Full Text] [Related]

  • 12. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H, Dallas L, Nair S, Palmer J, Thaikandy S, Hutchison C.
    Toxins (Basel); 2020 May 12; 12(5):. PubMed ID: 32408589
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
    Lewis SJ, Mueller BA.
    J Clin Pharmacol; 2021 Feb 12; 61(2):211-223. PubMed ID: 32851685
    [Abstract] [Full Text] [Related]

  • 15. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
    Truong J, Levkovich BJ, Padiglione AA.
    Intern Med J; 2012 Jan 12; 42(1):23-9. PubMed ID: 22276559
    [Abstract] [Full Text] [Related]

  • 16. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE, Fine A, Sitar DS, Rexrode S, Zelenitsky SA.
    Am J Kidney Dis; 2005 Oct 12; 46(4):681-7. PubMed ID: 16183423
    [Abstract] [Full Text] [Related]

  • 17. Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.
    Hui K, Patel K, Nalder M, Nelson C, Buising K, Pedagogos E, Kong DCM, Kirkpatrick CMJ.
    J Antimicrob Chemother; 2019 Jan 01; 74(1):130-134. PubMed ID: 30215721
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.